Cadence Raises $100 Million to Advance AI-Driven Chronic Disease Management
AI Platform Targets Chronic Disease Care
Cadence has raised $100 million to further develop and deploy its regulated AI system for chronic disease management. The funding round will support the company's efforts to automate various aspects of chronic care, including patient monitoring, medication management, and care coordination.
Regulatory Focus Sets Cadence Apart
Unlike many AI healthcare ventures that operate in regulatory gray areas, Cadence has positioned itself as a company working within existing healthcare regulations. This approach allows the company to integrate more seamlessly with existing healthcare systems and provider workflows.
Expanding Access to Chronic Care Management
Chronic diseases such as diabetes, hypertension, and heart disease require ongoing management and monitoring. The company aims to leverage AI to reduce the administrative burden on healthcare providers while improving patient outcomes through more consistent and timely interventions.